Related Experiment Video
Updated: Aug 8, 2026
Assessing Specificity of Anticancer Drugs In Vitro
Published on: March 23, 2016
New drugs for infections in patients with cancer
1St. Jude Children's Research Hospital, Memphis, Tennessee 38101-0318.
Background:
During the past several years, the treatment and prevention of infections in patients with cancer have improved because of the development of new antimicrobial drugs.
Methods:
A representative antibacterial, antifungal, and antiviral drug is discussed.
Results:
The fluoroquinolone compounds, such as ciprofloxacin, norfloxacin, and ofloxacin, have broad spectrum bactericidal activity and have proved to be effective in both the treatment and prevention of certain infections in patients with cancer. The triazole drug fluconazole is useful in the treatment of oral, esophageal, and disseminated candidiasis and cryptococcal meningitis. Early studies suggest that a new acyclic nucleoside, ganciclovir, has some effect in the treatment of cytomegalovirus infections, but its precise use in patients with cancer has not been fully established.
Conclusions:
New drugs currently available to the practitioner will improve management of infections in patients with cancer, but none is totally effective and the search for new compounds must continue.
Insights
New antimicrobial drugs improve cancer patient infection management. Fluoroquinolones, fluconazole, and ganciclovir show promise, but ongoing research for better treatments is essential.
Area of Science:
- Oncology
- Infectious Diseases
- Pharmacology
Background:
- Infections pose a significant risk to patients undergoing cancer treatment.
- Advances in antimicrobial drug development have enhanced infection control strategies.
Purpose of the Study:
- To review recent advancements in antimicrobial therapies for cancer patients.
- To highlight key antibacterial, antifungal, and antiviral agents.
Main Methods:
- Literature review of representative antimicrobial drugs.
- Discussion of drug classes including fluoroquinolones, triazoles, and acyclic nucleosides.
Main Results:
- Fluoroquinolones (e.g., ciprofloxacin) offer broad-spectrum activity against bacterial infections.
- Fluconazole is effective for candidiasis and cryptococcal meningitis.
- Ganciclovir shows potential for cytomegalovirus infections, though its role in cancer patients requires further study.
Conclusions:
- Current antimicrobial drugs improve infection management in cancer patients.
- No single agent is universally effective, necessitating continued development of novel compounds.
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Combined Effects of Drugs: Synergism
Such synergistic combinations...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...